• Nicotinamide Riboside Chloride in RGC Models

  2026-08-21

  Nicotinamide Riboside Chloride (NIAGEN) is best positioned as a controlled NAD+ metabolism variable layered onto, rather than substituted for, chemically defined retinal ganglion cell differentiation. This article maps practical dosing, assay controls, and troubleshooting strategies for connecting cellular energy state with reproducible iPSC-derived RGC outcomes.

• Dual Recombinase Tracing Finds No Postnatal Neo-Oogenesis

  2026-08-20

  Xie, Zhou, and Zheng used orthogonal Cre-loxP and Dre-rox lineage tracing to test whether postnatal ovarian cells generate new oocytes in mice. Across physiological aging and chemically induced ovarian injury, the study detected no labeled growing oocytes or metaphase II eggs, strengthening the conclusion that in vivo postnatal neo-oogenesis does not occur under the tested conditions.

• U3 snoRNA and DDX21 Coordinate Mitotic Control

  2026-08-19

  The 2024 Cell Death and Disease study shows that U3 snoRNA is an active regulator of mitosis rather than a passive chromosome passenger. It identifies a reciprocal U3–DDX21 relationship in the perichromosomal region, linking RNA mobility, condensate organization, and mitotic progression.

• Network Medicine Identifies Apigenin for Alzheimer’s

  2026-08-19

  A 2025 study used network medicine to prioritize flavonoids with proximity to Alzheimer’s disease targets and identified Apigenin as the strongest candidate among four experimentally validated compounds. Cellular experiments linked its neuroprotective activity to mitochondrial preservation, reduced apoptosis, AKT/NF-κB modulation, and suppression of microglia-associated inflammation.

• AI-10-49: From Fusion Target to AML Mechanism

  2026-08-18

  AI-10-49 is a CBFβ-SMMHC inhibitor that can do more than suppress leukemia growth: it provides a mechanistic probe for tracing RUNX1 restoration to the N-MYC/eIF4G1 survival program in inv(16) AML. This article presents a causality-centered strategy for connecting target engagement, chromatin remodeling, transcription, and leukemia phenotypes.

• Angiotensin I/II (1-5): RAS Workflow Guide

  2026-08-18

  Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for controlled renin-angiotensin system research involving blood pressure regulation, renal physiology, or aldosterone signaling. It should not be treated as a universal angiotensin substitute or used in unrelated signaling studies without independent validation of identity, solubility, dose, and assay response.

• Phosbind Acrylamide and the STK–EF-P Axis

  2026-08-17

  A mechanistic and translational perspective on how phosphate-dependent mobility shifts can strengthen phosphorylation analysis, using the STK–EF-P–serine protease pathway in Streptococcus suis as a model for antibody-independent validation.

• EdU Imaging Kits (HF594): Practical Guide

  2026-08-17

  EdU Imaging Kits (HF594) provide a practical way to detect S-phase DNA synthesis in fixed cells by coupling 5-ethynyl-2’-deoxyuridine incorporation to HyperFluor™ 594 fluorescence. The workflow is suitable for fluorescence microscopy and flow cytometry, but it should not be treated as a direct measure of total cell division or used for live-cell imaging without separate validation.

• SAG: Practical Hedgehog Pathway Activation Workflows

  2026-08-16

  SAG is a selective Smoothened receptor agonist for connecting Hedgehog pathway activation to measurable Gli1, Ptch1, alkaline phosphatase, mitochondrial, and myelin-related outcomes. This guide combines assay setup, model-specific use cases, dose planning, and troubleshooting for more reproducible developmental, stem cell, neurobiology, and tumorigenesis studies.

• Diethylmaleate for Redox and GST Assays

  2026-08-15

  Diethylmaleate enables controlled glutathione depletion, GST perturbation, and oxidative-stress phenotyping across cellular and insect toxicology workflows. This guide translates resistance biology into practical stock-preparation, co-exposure, readout, and troubleshooting strategies.

• Forsythoside E: An Assay-First PKM2 Strategy

  2026-08-15

  Forsythoside E is a pyruvate kinase M2 (PKM2) inhibitor with a distinctive immunometabolic mechanism linking PKM2 tetramerization, macrophage M2 polarization, and STAT3–NLRP3 control. This assay-first guide separates direct target engagement from downstream phenotypes and clarifies how to design stronger sepsis-induced liver injury research workflows.

• Schwartz on Measuring Cancer Drug Responses

  2026-08-14

  Hannah R. Schwartz’s dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures of anticancer activity. Its framework separates growth inhibition from cell killing and emphasizes that their proportions and timing can differ, providing a stronger basis for interpreting drug-response experiments.

• Gefitinib (ZD1839) EGFR Research Workflows

  2026-08-14

  Build cleaner EGFR mechanism studies with Gefitinib (ZD1839), from phosphorylation assays and cancer-cell phenotyping to blue-light barrier models. This workflow pairs literature-defined exposure systems with practical controls, dosing guidance, and troubleshooting steps.

• Hoechst 33342 for Fibroblast Senescence Assays

  2026-08-13

  Hoechst 33342 Solution (1 mg/mL) supports rapid nuclear labeling in live and fixed human dermal fibroblasts, providing a practical counterstain for microscopy, cell counting, and flow cytometry. This guide connects nuclear readouts with pterostilbene-driven mitochondrial quality studies and offers executable starting conditions plus troubleshooting strategies.

• Localized BDNF Release in Early NMJ Formation

  2026-08-13

  This study identifies podosome-like structures as localized platforms for muscle-derived BDNF trafficking and calcium-dependent release during the earliest stages of neuromuscular junction development. Its genetic and pharmacological evidence links BDNF abundance and proteolytic processing to aneural and nerve-induced acetylcholine receptor clustering, providing a spatially resolved framework for studying postsynaptic assembly.

448 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page